Oxford Biomedica Share News (OXB)

STOCKS NEWS EUROPE-Oxford BioMedica up on Novartis deal

Shares in Oxford BioMedica rise 15 percent after the gene-based biopharmaceutical specialist signs a deal to make clinical grade material for Novartis
[1 May '13]

STOCKS NEWS EUROPE-UK small caps edge down 0.1 pct early on

The FTSE Small Cap index sheds 0.1 percent in early deals, underperforming its larger peers with the FTSE 100 up 0.4 percent and the FTSE 250 rising 0
[1 May '13]

BRIEF-Oxford Biomedica says ImaginAb exercises option for licence

LONDON, Nov 29 (Reuters) - Oxford BioMedica PLC: * Imaginab acquires exclusive worldwide licence for 5t4-based imaging diagnostic
[29 Nov '12]

UPDATE 1-Oxford Bio abandons prostate cancer vaccine study

LONDON, Oct 10 (Reuters) - Britain's Oxford BioMedica said on Wednesday it was closing a mid-stage clinical trial of its cancer vaccine TroVax
[10 Oct '12]

BRIEF-Oxford Bio to close prostate cancer study in U.S.

LONDON, Oct 10 (Reuters) - Oxford BioMedica PLC: * To close phase II study in US to assess Trovax in patients with prostate cancer
[10 Oct '12]

BRIEF-Oxford Biomedica to place 11 mln stg

LONDON, June 29 (Reuters) - Oxford BioMedica PLC: * Proposed firm placing of £11 million and open offer of up to £5 million ((London
[29 Jun '12]

BRIEF-Oxford Biomedica's manufacturing facility approved

LONDON, June 8 (Reuters) - Oxford BioMedica PLC: * Approval from the UK mhra for manufacturing facility in cowley, Oxford ((London Eq
[8 Jun '12]

BRIEF-Oxford Biomedica presents ocular clinical data

LONDON, May 8 (Reuters) - Oxford BioMedica PLC: * Presentation of ocular clinical data at arvo * Early retinostat data indicate susta
[8 May '12]